Compare Trip.com Group Ltd (TCOM) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Trip.com Group Ltd vs Tenet Healthcare Corporation — how do they compare? Trip.com Group Ltd trades at $38.91 (market cap $23.75B), while Tenet Healthcare Corporation trades at $263.45 (market cap $20.98B). The key difference: Trip.com Group Ltd and Tenet Healthcare Corporation are close in size by market cap, and Trip.com Group Ltd pays a 0.42% dividend while Tenet Healthcare Corporation pays none. Which is the better fit depends on your goals — on Pluang, investors hold Trip.com Group Ltd for 79 Days and Tenet Healthcare Corporation for 15 Days on average.
| TCOM | THC | |
|---|---|---|
Market Cap | $23.75B | $20.98B |
Volume | 2,089,737 | 428,008 |
Sector | Consumer Cyclical | Health |
52-Week High | $78.96 | $280.77 |
52-Week Low | $37.96 | $161.37 |
Typical Hold Time | 79 Days | 15 Days |
Enterprise Value | $15.91B | $32.06B |
Dividend Yield | 0.42% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Trip.com Group (TCOM) trades at $38.89, up 2.1% with mixed technical signals showing bearish moving averages but oversold RSI conditions. The company demonstrates strong fundamentals with revenue growing from $20.0B in 2022 to $62.4B in 2025, maintaining robust 36.9% net margins. Recent Q2 2026 earnings beat expectations at $1.07 per share versus $0.98 estimate, though regulatory headwinds from Chinese antitrust actions create uncertainty.
The stock presents a compelling value opportunity with low P/E of 7.34 and significant 46% upside to consensus price target of $56.64, supported by 70% analyst buy ratings. However, regulatory pressure on pricing algorithms and geopolitical risks require careful monitoring given the bearish technical setup and recent price volatility.
Tenet Healthcare (THC) trades at $265.42, up 2.15% today, with a bullish technical signal from moving averages and strong support near $257. The company shows robust fundamentals, including a 53.31% ROE and consistent earnings beats, with Q3 2026 results due October 29. Revenue growth is supported by higher revenue per case despite softer surgical volumes, as noted by Zacks on September 24, 2026.
The outlook is positive, with an 81.25% analyst buy rating and a $283.36 consensus price target implying ~7% upside. Risks include sustainability of capital returns amid growth investments and potential volume pressures, but solid cash flow and valuation metrics like a 10.07 P/E suggest room for appreciation if execution continues.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Trip.com Group Ltd
Trip.com is the largest online travel agent in China and is positioned to benefit from the country's rising demand for higher-margin outbound travel as passport penetration is only 12% in China. The company generated about 78% of sales from accommodation reservations and transportation ticketing in 2020. The rest of revenue comes from package tours and corporate travel. Prior to the pandemic in 2019, the company generated 25% of revenue from international business, which is important to its margin expansion. Most of sales come from websites and mobile platforms, while the rest come from call centers. The competes in a crowded OTA industry in China, including Meituan, Alibaba-backed Fliggy, Toncheng, and Qunar. The company was founded in 1999 and listed on the Nasdaq in December 2003.
Read more on TCOM →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
